Showing results (171-180 of 424) with videos related to

Sort By:
Pageof 43
Gastroenterology|May 2, 2002
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CThierry Poynard, John McHutchison, Michael Manns, et al.
Future Oncology (London, England)|July 10, 2015
Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON studyBruno Daniele, Adina Croitoru, Christos Papandreou, et al.
World Journal of Gastroenterology|May 20, 2015
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC studyBenjamin Terrier, Nathanael Lapidus, Stanislas Pol, et al.
Contemporary Clinical Trials|October 11, 2020
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkersStephen A Harrison, Salvatore Calanna, Kenneth Cusi, et al.
Plos One|August 21, 2012
Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyHelmi M'Kada, Hugo Perazzo, Mona Munteanu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|August 25, 2022
The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United StatesAndreas Geier, Sabina Heinz, Maria-Magdalena Balp, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 27, 2020
Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision AnalysisAris Angelis, Mark Thursz, Vlad Ratziu, et al.
The New England Journal of Medicine|November 13, 2020
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisPhilip N Newsome, Kristine Buchholtz, Kenneth Cusi, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Metabolism: Clinical and Experimental|July 14, 2024
Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative reviewMarta Bento Afonso, Jan Caira David, Mariana Isabel Alves, et al.
Pageof 43